Literature DB >> 8617864

Tolerance to factor VIII inhibitors in hemophilia A patients: a French twist.

V Pascual, J D Capra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8617864      PMCID： PMC507191          DOI： 10.1172/JCI118553

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  14 in total

1.  Noncoagulation inhibitory factor VIII antibodies after induction of tolerance to factor VIII in hemophilia A patients.

Authors:  I M Nilsson; E Berntorp; O Zettervall; B Dahlbäck
Journal:  Blood       Date:  1990-01-15       Impact factor: 22.113

2.  Incidence of inhibitors in patients with severe and moderate hemophilia A treated with factor VIII concentrates.

Authors:  I Schwarzinger; I Pabinger; C Korninger; F Haschke; M Kundi; H Niessner; K Lechner
Journal:  Am J Hematol       Date:  1987-03       Impact factor: 10.047

3.  Acquired circulating anticoagulants in hemophilia A.

Authors:  H S Strauss
Journal:  N Engl J Med       Date:  1969-10-16       Impact factor: 91.245

4.  Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.

Authors:  Y Sultan; M D Kazatchkine; P Maisonneuve; U E Nydegger
Journal:  Lancet       Date:  1984-10-06       Impact factor: 79.321

5.  Factor VIII epitopes recognized with inhibitory monoclonal antibodies.

Authors:  C Y Tiarks; R E Humphreys; L Pechet
Journal:  Acta Haematol       Date:  1990       Impact factor: 2.195

6.  Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder.

Authors:  H H Brackmann; J Gormsen
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

7.  Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.

Authors:  Y Sultan; F Rossi; M D Kazatchkine
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

8.  Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs.

Authors:  S Ehrenforth; W Kreuz; I Scharrer; R Linde; M Funk; T Güngör; B Krackhardt; B Kornhuber
Journal:  Lancet       Date:  1992-03-07       Impact factor: 79.321

9.  Characterization of four monoclonal antibodies to factor VIII coagulant protein and their use in immunopurification of factor VIII.

Authors:  M P Croissant; H van de Pol; H H Lee; J P Allain
Journal:  Thromb Haemost       Date:  1986-12-15       Impact factor: 5.249

10.  Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A.

Authors:  J G Gilles; B Desqueper; H Lenk; J Vermylen; J M Saint-Remy
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.